For decades, food and drink manufacturers have relied on a predictable formula: calibrated levels of sugar and fat to trigger the brain’s reward pathways, drive impulse purchases and encourage repeat consumption.

GLP‑1 medications disrupt that model at its core. As Martha Wood, marketing lead at Ulrick + Short, explains, these drugs “effectively ‘mute’ the brain’s reward centre for sugar and fat,” reducing the neurological payoff that has historically underpinned indulgence-led categories.

This shift doesn’t just dampen cravings — it changes the very mechanics of satisfaction. If sweetness and richness no longer deliver the same reward, brands must rethink how pleasure is engineered. Texture, Wood argues, becomes the new frontier. “Products have been built around palatability… If that neurological response is softened, brands can’t rely on sweetness and richness alone. Texture has become far more important.”

Manufacturers are now exploring layered structures, coatings, aeration, sound and visual cues to recreate the sensory engagement that sugar and fat once provided. In other words: indulgence is no longer a flavour problem — it’s a structural one.

The household halo: why retailers must speak to the ‘influenced non‑user’

One of the most overlooked dynamics of the GLP‑1 boom is the household effect. When one person starts the medication, the entire family’s shopping basket shifts. Retailers, Wood says, should avoid targeting “GLP‑1 users” explicitly and instead focus on universal value propositions: high protein, fibre enrichment, portion control and balanced formulations.

Protein has already gone mainstream; fibre is rapidly following. But in a crowded better‑for‑you aisle, differentiation hinges on clarity of purpose. “Retailers should look at not just stating a claim but articulating why that nutrient matters and how it supports satiety, digestive comfort or sustained energy,” Wood notes.

This is a subtle but important shift: the GLP‑1 consumer isn’t looking for diet food — they’re looking for food that works harder.

The nutrient density mandate: when every bite counts

With many GLP‑1 users consuming as little as 1,200 calories a day, nutrient density becomes non‑negotiable. But fortifying small‑format foods with high levels of protein and fibre is technically challenging.

Protein competes for water, often causing dryness or firmness. Fibre can disrupt structure, reduce volume and introduce digestive tolerance issues at higher inclusion levels. “Successful products are those that integrate nutrients within a balanced system rather than layering them on top,” Wood explains.

This requires smarter ingredient systems — ones that deliver nutrition without compromising texture, moisture or shelf life. It’s a formulation puzzle that rewards technical sophistication over simple swaps.

Beyond diet food: the rise of functional, clean‑label GLP‑1‑friendly formulations

Traditional weight‑loss products were defined by removal — less fat, less sugar, fewer calories — often at the expense of taste and texture. GLP‑1‑influenced consumers expect more. They want foods that deliver meaningful value within a smaller intake: protein for muscle retention, fibre for digestive support, balanced macronutrients for sustained energy.

Crucially, clean‑label expectations remain high. “Consumers are not necessarily demanding the shortest ingredient list, but ingredients that are recognisable and purposeful,” Wood says.

This is where multifunctional ingredients come into play. Soluble fibre‑based sugar replacers, for example, can reduce sugar while adding nutritional positives. The future of GLP‑1‑friendly innovation lies in ingredients that do more than one job — technically and nutritionally.

Texture as the new indulgence: designing lightness without losing satisfaction

Appetite suppression often brings an aversion to heavy, greasy foods. Yet consumers still expect indulgence. Manufacturers are turning to advanced starch‑based fat mimetics and functional fibres to recreate smoothness, mouthfeel and bulk without the caloric load.

As Wood explains, “This requires reformulation strategies that replicate the structural properties of fat without equivalent caloric contribution.”

The goal is to redesign mouthfeel so it aligns with new appetite cues — lighter, cleaner, less greasy — while still delivering sensory reward.

Right‑sizing vs. shrinkflation: a communications challenge

As brands move toward smaller, pre‑portioned meals, they risk being caught in the crossfire of shrinkflation scepticism. The solution is transparency. Clear calorie communication, satiety messaging and framing portion size as intentional — not cost‑cutting — will be essential to maintaining trust.

Winners, losers and the portfolio pivot

Confectionery and salty snacks are naturally exposed to reduced impulse consumption. But Wood argues that both reformulation and diversification offer viable paths forward.

Portion‑controlled formats, protein enrichment and fibre fortification can extend relevance without abandoning brand identity. Meanwhile, diversification into functional categories — especially those addressing GLP‑1 side effects like digestive discomfort or dehydration — opens new growth avenues.

This is not a story of category decline; it’s a story of category evolution.

The 2026 patent cliff: preparing for mass‑market GLP‑1 adoption

With semaglutide set to go off‑patent in several regions by 2026, affordable generics will accelerate adoption. Is the industry ready?

Wood believes many brands already have a head start. “Protein moved into the mainstream before GLP‑1 became widely discussed, and fibre is rapidly following,” she notes. Existing products may simply need repositioning or incremental optimisation.

The next wave of innovation will favour multifunctional ingredient solutions that deliver multiple benefits simultaneously — efficiency will be key as penetration increases.

Rethinking ultra‑processed: cleaner, smarter, more transparent

GLP‑1 doesn’t eliminate demand for ready meals or snacks. Instead, it increases scrutiny of composition. The debate around UPFs, Wood argues, “often centres on ingredient perception rather than processing itself.”

Convenience remains essential — but so does credibility. Multifunctional ingredients that replace multiple additives while maintaining structure will become increasingly valuable. GLP‑1 is likely to accelerate the evolution toward cleaner, more efficient formulations rather than kill the category outright.